| Product Name | Research Grade Tibulizumab |
|---|---|
| Target | CTLA-8, Cytotoxic T-lymphocyte-associated antigen 8, IL17, IL-17A, IL17A, CTLA8, IL-17, Interleukin-17A, BAFF, ZTNF4, BLYS, Tumor necrosis factor ligand superfamily member 13B, Dendritic cell-derived TNF-like molecule, TALL-1, TNF- and APOL-related leukocyte expressed ligand 1, BLyS, B lymphocyte stimulator, TNFSF13B, CD257, TNFSF20, TALL1, B-cell-activating factor |
| source | Humanized |
| Clonality | Monoclonal |
| Isotype | IgG4-kappa-[scFv]2 |
| Reactivity | Human |
| Endotoxin | Please contact with the lab for this information. |
| Purification | Protein A/G purified from cell culture supernatant. |
| Purity | >95% as determined by SDS-PAGE. |
| Application | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Form | Liquid |
| Formulation | 0.01M PBS, pH 7.4. |
| Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
